BIIB - Biogen scraps Aduhelm will focus on other Alzheimer's drugs
2024-01-31 09:54:28 ET
More on Biogen
- Biotech And Pharma Diversification Pays Off
- Biogen Inc. (BIIB) JPMorgan 42nd Annual Healthcare Conference (Transcript)
- Biogen: LEQEMBI's $10 Billion Potential
- Biogen slips as UBS cuts to Neutral on Alzheimer’s drug uptake
- Eisai, Biogen file for EU marketing authorization of Alzheimer's drug